These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 23339812)
1. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents. Pilgrim T; Kalesan B; Zanchin T; Pulver C; Jung S; Mattle H; Carrel T; Moschovitis A; Stortecky S; Wenaweser P; Stefanini GG; Räber L; Meier B; Jüni P; Windecker S EuroIntervention; 2013 Jan; 8(9):1061-71. PubMed ID: 23339812 [TBL] [Abstract][Full Text] [Related]
2. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents. Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773 [TBL] [Abstract][Full Text] [Related]
3. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143 [TBL] [Abstract][Full Text] [Related]
4. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study. Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE; Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437 [TBL] [Abstract][Full Text] [Related]
5. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting. Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Friberg L; Rosenqvist M; Lip GY Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443 [TBL] [Abstract][Full Text] [Related]
7. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents. Kersting S; Grumann T; Hummel J; Hauschke D; Bode C; Hehrlein C Crit Pathw Cardiol; 2012 Sep; 11(3):152-9. PubMed ID: 22825536 [TBL] [Abstract][Full Text] [Related]
8. Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention. Yoon YH; Kim YH; Kim SO; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ Catheter Cardiovasc Interv; 2015 Jan; 85(1):63-71. PubMed ID: 24282105 [TBL] [Abstract][Full Text] [Related]
9. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018 [TBL] [Abstract][Full Text] [Related]
10. Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era. Midwall S; Swaminathan RV; Charitakis K; Kim LK; Gordin J; Hriljac I; Minutello RM; Bergman G; Wong SC; Feldman DN J Invasive Cardiol; 2013 Mar; 25(3):132-6. PubMed ID: 23468442 [TBL] [Abstract][Full Text] [Related]
11. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066 [TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents. Miao Y; Yu-Jie Z; Zhi-Jian W; Dong-Mei S; Yu-Yang L; Ying-Xin Z; Fei G; Shi-Wei Y; De-An J Catheter Cardiovasc Interv; 2012 Sep; 80(3):361-7. PubMed ID: 22419375 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry. Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993 [TBL] [Abstract][Full Text] [Related]
14. Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease. Niccoli G; Sgueglia GA; Cosentino N; Piro M; Toma A; Cataneo L; Fracassi F; Porto I; Leone AM; Burzotta F; Trani C; Crea F Eur J Prev Cardiol; 2012 Oct; 19(5):914-26. PubMed ID: 21840968 [TBL] [Abstract][Full Text] [Related]
16. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637 [TBL] [Abstract][Full Text] [Related]
17. Impact of ad hoc percutaneous coronary intervention with drug-eluting stents in angina patients. Kim YH; Park DW; Ahn JM; Park GM; Cho YR; Lee JY; Kim WJ; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ; EuroIntervention; 2013 May; 9(1):110-7. PubMed ID: 23685299 [TBL] [Abstract][Full Text] [Related]
18. Selection of Stent Type in Patients With Atrial Fibrillation Presenting With Acute Myocardial Infarction: An Analysis From the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-Get With the Guidelines. Vora AN; Wang TY; Li S; Chiswell K; Hess C; Lopes RD; Rao SV; Peterson ED J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862960 [TBL] [Abstract][Full Text] [Related]
19. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up. Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070 [TBL] [Abstract][Full Text] [Related]
20. Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting. Marcolino MS; Simsek C; de Boer SP; van Domburg RT; van Geuns RJ; de Jaegere P; Akkerhuis KM; Daemen J; Serruys PW; Boersma E EuroIntervention; 2012 Dec; 8(8):920-8. PubMed ID: 22709564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]